NO20003312L - <Gamma>-glutamyl og <beta>-aspartyl inneholdende immunmodulator-forbindelser og fremgangsmÕter derav - Google Patents

<Gamma>-glutamyl og <beta>-aspartyl inneholdende immunmodulator-forbindelser og fremgangsmÕter derav

Info

Publication number
NO20003312L
NO20003312L NO20003312A NO20003312A NO20003312L NO 20003312 L NO20003312 L NO 20003312L NO 20003312 A NO20003312 A NO 20003312A NO 20003312 A NO20003312 A NO 20003312A NO 20003312 L NO20003312 L NO 20003312L
Authority
NO
Norway
Prior art keywords
glutamyl
gamma
beta
methods
immunomodulator compounds
Prior art date
Application number
NO20003312A
Other languages
English (en)
Other versions
NO20003312D0 (no
NO317256B1 (no
Inventor
Edward T Wei
Alexander A Kolobov
Andrey S Simbirtsev
Original Assignee
Edward T Wei
Alexander A Kolobov
Andrey S Simbirtsev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26653944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003312(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU97120940/04A external-priority patent/RU2142958C1/ru
Application filed by Edward T Wei, Alexander A Kolobov, Andrey S Simbirtsev filed Critical Edward T Wei
Publication of NO20003312D0 publication Critical patent/NO20003312D0/no
Publication of NO20003312L publication Critical patent/NO20003312L/no
Publication of NO317256B1 publication Critical patent/NO317256B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003312A 1997-12-25 2000-06-23 <Gamma>-glutamyl og <beta>-aspartyl inneholdende immunmodulator-forbindelser og fremgangsmater derav NO317256B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU97120940/04A RU2142958C1 (ru) 1997-12-25 1997-12-25 Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
US09/031,842 US5916878A (en) 1995-11-28 1998-02-27 γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
PCT/US1998/027291 WO1999033799A1 (en) 1997-12-25 1998-12-22 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith

Publications (3)

Publication Number Publication Date
NO20003312D0 NO20003312D0 (no) 2000-06-23
NO20003312L true NO20003312L (no) 2000-08-21
NO317256B1 NO317256B1 (no) 2004-09-27

Family

ID=26653944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003312A NO317256B1 (no) 1997-12-25 2000-06-23 <Gamma>-glutamyl og <beta>-aspartyl inneholdende immunmodulator-forbindelser og fremgangsmater derav

Country Status (14)

Country Link
US (1) US5916878A (no)
EP (1) EP1042286B1 (no)
JP (1) JP4536918B2 (no)
KR (2) KR100623104B1 (no)
CN (1) CN1155571C (no)
AU (1) AU754876B2 (no)
BR (1) BR9814472A (no)
CA (1) CA2316310C (no)
CY (1) CY1111236T1 (no)
IL (1) IL136937A0 (no)
MX (1) MXPA00006369A (no)
NO (1) NO317256B1 (no)
NZ (1) NZ505489A (no)
WO (1) WO1999033799A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2089179C1 (ru) * 1995-12-14 1997-09-10 Закрытое акционерное общество "ВАМ" Стимулятор эндогенной продукции цитокинов и гепопоэтических факторов и способ его использования
US6251857B1 (en) 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US20070142267A1 (en) * 1998-11-23 2007-06-21 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
RU2144374C1 (ru) 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
AU4222200A (en) * 1999-04-15 2000-11-02 Thymon L.L.C. Nonextractive method of assaying thymopoietin
JP2004503604A (ja) * 2000-07-24 2004-02-05 ザ・ユニバーシティ・オブ・クイーンズランド 化合物およびホスホリパーゼ阻害剤
AU2001272234B2 (en) * 2000-07-24 2006-06-01 The University Of Queensland Compounds and inhibitors of phospholipases
US7173013B2 (en) * 2001-06-08 2007-02-06 Sciclone Pharmaceuticals, Inc. Treatment of tuberculosis using immunomodulator compounds
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
CN1964731A (zh) * 2004-05-14 2007-05-16 希克龙制药公司 用免疫调节剂化合物治疗或预防呼吸道病素性感染
SG163601A1 (en) * 2004-10-27 2010-08-30 Sciclone Pharmaceuticals Inc Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
US20090074815A1 (en) * 2005-04-22 2009-03-19 Sciclone Pharmaceuticals, Inc. Immunomodulator Compounds as Vaccine Enhancers
WO2007123847A2 (en) * 2006-04-20 2007-11-01 Sciclone Pharmaceuticals, Inc. Treatment of melanoma
RU2301074C1 (ru) * 2006-05-30 2007-06-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, обладающий иммуногеропротекторным действием, фармацевтическая композиция на его основе и способ ее применения
CA2569204A1 (en) 2006-11-28 2008-05-28 Apotex Technologies Inc. Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan
CA2571645A1 (en) * 2006-12-19 2008-06-19 Apotex Technologies Inc. Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
EP2120986A4 (en) * 2007-02-13 2010-04-07 Sciclone Pharmaceuticals Inc METHOD FOR THE TREATMENT OR PREVENTION OF TISSUE WEAR, INJURY OR DAMAGE CAUSED BY SLEWER DISEASES
CA2579119C (en) * 2007-02-16 2013-03-05 Apotex Technologies Inc. Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
RU2007118237A (ru) * 2007-05-17 2008-11-27 ООО "Научно-производственна фирма Верта" (RU) Способ лечения аллергических заболеваний
CN101842009A (zh) * 2007-08-23 2010-09-22 赛生制药有限公司 肺癌的治疗
CN102265160B (zh) * 2008-12-24 2014-07-23 学校法人庆应义塾 肝病标记物、其测定方法、装置和医药品的检验方法
US20110064828A1 (en) * 2009-09-11 2011-03-17 Novelos Therapeutics, Incorporated Treatment of metastatic tumors and other conditions
WO2012040656A2 (en) * 2010-09-24 2012-03-29 Sciclone Pharmaceuticals, Inc. Biomarkers to track response to scv-07
RU2436587C1 (ru) * 2010-10-21 2011-12-20 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") N-изовалероил-l-глутамил-l-триптофан как средство, препятствующее язвообразованию в желудке и двенадцатиперстной кишке
CN102417474B (zh) * 2011-09-26 2014-07-02 深圳翰宇药业股份有限公司 D-异谷氨酰基-d-色氨酸制备的新方法
WO2013155595A1 (en) * 2012-04-18 2013-10-24 Apotex Technologies Inc. Process for the preparation of a monosodium salt of h-d-glu-(l-trp-oh)-oh and a crystalline form thereof
WO2013155592A1 (en) * 2012-04-18 2013-10-24 Apotex Technologies Inc. Crystal forms of golotimod and process for its manufacturing
RU2635968C1 (ru) * 2016-11-17 2017-11-17 Аллан Герович Бениашвили Способ лечения и профилактики состояний аллергического спектра

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125626A (en) * 1977-01-17 1978-11-14 Mt. Sinai School Of Medicine Of The City University Of New York Synthesis and use of L-γ-glutamyl-DOPA
US4568489A (en) * 1984-06-29 1986-02-04 E. R. Squibb & Sons, Inc. N-Acyl-γ-glutamyl imino and amino acids and esters
US4758551A (en) * 1986-07-08 1988-07-19 Cornell Research Foundation, Inc. Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
US5206220A (en) * 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
CA2107460A1 (en) * 1991-04-01 1992-10-02 Vladimir K. Khavinson Pharmaceutical dipeptide compositions and methods of use thereof
GB9113219D0 (en) * 1991-06-19 1991-08-07 Fujisawa Pharmaceutical Co Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
WO1993008815A1 (en) * 1991-10-28 1993-05-13 Cytoven Pharmaceutical dipeptide compositions and methods of use thereof
WO1994020063A2 (en) * 1993-03-04 1994-09-15 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
RU2107692C1 (ru) * 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
WO1997019691A1 (en) * 1995-11-28 1997-06-05 Wei, Edward, T. Gamma-l-glutamyl containing immunomodulator compounds and methods therewith

Also Published As

Publication number Publication date
NO20003312D0 (no) 2000-06-23
CA2316310A1 (en) 1999-07-08
IL136937A0 (en) 2001-06-14
NO317256B1 (no) 2004-09-27
NZ505489A (en) 2003-02-28
KR100602529B1 (ko) 2006-07-19
WO1999033799A1 (en) 1999-07-08
AU754876B2 (en) 2002-11-28
KR100623104B1 (ko) 2006-09-15
KR20060057027A (ko) 2006-05-25
CY1111236T1 (el) 2015-06-11
AU2090999A (en) 1999-07-19
JP2001527065A (ja) 2001-12-25
US5916878A (en) 1999-06-29
BR9814472A (pt) 2001-10-23
CA2316310C (en) 2008-02-19
CN1155571C (zh) 2004-06-30
CN1284943A (zh) 2001-02-21
MXPA00006369A (es) 2002-08-06
JP4536918B2 (ja) 2010-09-01
EP1042286B1 (en) 2010-08-25
KR20010033617A (ko) 2001-04-25
EP1042286A1 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
DE69728358D1 (de) Gammakamera
NO991151D0 (no) Forbindelse og anvendelse derav
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO983904D0 (no) Agglomerater inneholdende &lt;beta&gt;-laktamforbindelser
DE69517547D1 (de) Strahlungsempfindliche Mischung
NO20003312D0 (no) Gamma-glutamyl og beta-aspartyl inneholdende immunmodulator- forbindelser og fremgangsmÕter derav
FI935724A0 (fi) (S)(+)-2-etoksi-4-/N-/1-(2-piperidinofenyl)-3-metyl-1-butyl/aminokarbonylmetyl/-bensoesyra
NO965327D0 (no) Sporbare brönnsementsammensetninger og metoder
NO943763D0 (no) 4-arylamino-benzopyraner og beslektede forbindelser
DE69525311D1 (de) Photovervielfacher
NO995324L (no) Baerer for gjenstander og emne for denne
DE69930692D1 (de) Gammakamera
DE69506999D1 (de) Strahlungsempfindliche Zusammensetzung
DE59501350D1 (de) Acylierte gamma-Cyclodextrine
DE69404540D1 (de) Photovervielfacher
DE69534677D1 (de) Gammakamerasystem
DE69714727D1 (de) Amorphe fällungskieselsäure
DE69403857D1 (de) Photovervielfacher
DE69512695D1 (de) Photovervielfacher
DE69406709D1 (de) Photovervielfacher
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
DE69404079D1 (de) Photovervielfacher
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
DE69404538D1 (de) Photovervielfacher
FI943815A7 (fi) Röntgensäteillä fluoresoiva tutkimuslaite

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees